• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗患者围手术期血压变化及其与主要不良心血管事件的关系:一项横断面研究

Peri-Procedural Blood Pressure Changes and Their Relationship with MACE in Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study.

作者信息

Labib Susan, Kassem Hussein Heshmat, Kandil Hossam

机构信息

Department of Cardiology, Cairo University, Cairo, Egypt.

出版信息

Integr Blood Press Control. 2020 Dec 10;13:187-195. doi: 10.2147/IBPC.S268848. eCollection 2020.

DOI:10.2147/IBPC.S268848
PMID:33335422
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7736835/
Abstract

BACKGROUND

Peri-procedural blood-pressure (BP) changes were investigated and correlated to Major adverse cardiovascular events (MACE) as predictor of outcome for patients undergoing percutaneous coronary intervention (PCI); whether acute coronary syndrome (Unstable angina, or MI; STEMI or NSTEMI) or scheduled for elective PCI.

METHODS

Resting BP in the 204 recruited patients undergoing PCI throughout 2018 was measured thrice - in the ward before transferring to the cardiac catheterization lab (cath lab), in the cath lab, and after transfer to the recovery room. Patients were categorized based on their systolic and diastolic BP peri-procedural difference as systolic (SBP): with a large difference (>20 mmHg, n=47), with a small difference (≤20 mmHg, n=157) (shock patients excluded); diastolic (DBP): with a large difference (>10 mmHg, n=65), and with a small difference (≤10 mmHg, n=139). The primary end-points were MACE including all-cause mortality, non-fatal myocardial infarction, and stroke during the hospital stay. The Mann-Whitney U and Chi-square tests were used to analyze the data accordingly (p<0.005).

RESULTS

Within the category of MACE, cardiac mortality was the only adverse cardiac event encountered in the study sample. Cardiac mortality was significantly higher in both the large SBP-difference group versus the other group (10.6% vs 0.6%, p=0.003) and the large DBP-difference group versus the small-difference group (7.7% vs 0.7%, p=0.013).

CONCLUSION

Peri-procedural systolic and diastolic BP differences, greater than 20 mmHg and 10 mmHg, respectively, correlated with MACE in all patients undergoing PCI.

摘要

背景

研究了经皮冠状动脉介入治疗(PCI)患者围手术期血压(BP)变化,并将其与主要不良心血管事件(MACE)相关联,作为预测患者预后的指标;这些患者包括急性冠状动脉综合征(不稳定型心绞痛或心肌梗死;ST段抬高型心肌梗死或非ST段抬高型心肌梗死)或计划进行择期PCI的患者。

方法

对2018年接受PCI的204例患者的静息血压进行了三次测量——在转送至心导管实验室(导管室)之前在病房测量、在导管室测量以及转至恢复室后测量。根据患者围手术期收缩压和舒张压的差异将患者分类为:收缩压(SBP):差异大(>20 mmHg,n = 47)、差异小(≤20 mmHg,n = 157)(排除休克患者);舒张压(DBP):差异大(>10 mmHg,n = 65)、差异小(≤10 mmHg,n = 139)。主要终点是住院期间的MACE,包括全因死亡率、非致命性心肌梗死和中风。相应地使用曼-惠特尼U检验和卡方检验分析数据(p<0.005)。

结果

在MACE类别中,心脏死亡率是研究样本中唯一遇到的不良心脏事件。SBP差异大的组与另一组相比,心脏死亡率显著更高(10.6%对0.6%,p = 0.003),DBP差异大的组与差异小的组相比,心脏死亡率也显著更高(7.7%对0.7%,p = 0.013)。

结论

围手术期收缩压和舒张压差异分别大于20 mmHg和10 mmHg与所有接受PCI的患者的MACE相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0d/7736835/87c93671a7d8/IBPC-13-187-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0d/7736835/b4667da0be08/IBPC-13-187-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0d/7736835/87c93671a7d8/IBPC-13-187-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0d/7736835/b4667da0be08/IBPC-13-187-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb0d/7736835/87c93671a7d8/IBPC-13-187-g0002.jpg

相似文献

1
Peri-Procedural Blood Pressure Changes and Their Relationship with MACE in Patients Undergoing Percutaneous Coronary Intervention: A Cross-Sectional Study.经皮冠状动脉介入治疗患者围手术期血压变化及其与主要不良心血管事件的关系:一项横断面研究
Integr Blood Press Control. 2020 Dec 10;13:187-195. doi: 10.2147/IBPC.S268848. eCollection 2020.
2
Differences in ward-to-cath lab systolic blood pressure predicts long-term adverse outcomes after drug-eluting stent implantation.病房至导管室收缩压的差异可预测药物洗脱支架植入术后的长期不良结局。
Heart Vessels. 2015 Nov;30(6):740-5. doi: 10.1007/s00380-014-0550-3. Epub 2014 Jul 26.
3
Association between inter-leg blood pressure difference and cardiovascular outcome in patients undergoing percutaneous coronary intervention.双腿血压差值与行经皮冠状动脉介入治疗患者心血管结局的相关性。
PLoS One. 2021 Oct 15;16(10):e0257443. doi: 10.1371/journal.pone.0257443. eCollection 2021.
4
Impact of Pre-Procedural Blood Pressure on Long-Term Outcomes Following Percutaneous Coronary Intervention.经皮冠状动脉介入治疗术前血压对长期预后的影响。
J Am Coll Cardiol. 2019 Jun 11;73(22):2846-2855. doi: 10.1016/j.jacc.2019.03.493.
5
Value of peri-procedural B-type natriuretic peptide levels in predicting cardiac events after elective percutaneous coronary intervention.择期经皮冠状动脉介入治疗后围手术期B型利钠肽水平对预测心脏事件的价值
Acta Cardiol. 2008 Feb;63(1):47-52. doi: 10.2143/AC.63.1.2025331.
6
Effects of Danhong Injection () on Peri-Procedural Myocardial Injury and Microcirculatory Resistance in Patients with Unstable Angina Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.丹红注射液对择期经皮冠状动脉介入治疗不稳定型心绞痛患者围术期心肌损伤及微循环阻力的影响:一项初步随机研究。
Chin J Integr Med. 2021 Nov;27(11):846-853. doi: 10.1007/s11655-021-2872-1. Epub 2021 Jul 14.
7
Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention.平均血小板体积与经皮冠状动脉介入治疗后的主要不良心脏事件。
Arch Iran Med. 2019 Apr 1;22(4):198-203.
8
Association between DBP and major adverse cardiovascular events in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.DBP 与经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者主要不良心血管事件的关系。
J Hypertens. 2022 Apr 1;40(4):692-698. doi: 10.1097/HJH.0000000000003062.
9
Blood Pressure Targets and Clinical Outcomes in Patients with Acute Myocardial Infarction.急性心肌梗死患者的血压目标与临床结局
Korean Circ J. 2017 Jul;47(4):446-454. doi: 10.4070/kcj.2017.0008. Epub 2017 Jul 12.
10
One-year Outcomes in Patients with ST-segment Elevation Myocardial Infarction Caused by Unprotected Left Main Coronary Artery Occlusion Treated by Primary Percutaneous Coronary Intervention.直接经皮冠状动脉介入治疗无保护左主干冠状动脉闭塞所致 ST 段抬高型心肌梗死患者 1 年的转归。
Chin Med J (Engl). 2018 Jun 20;131(12):1412-1419. doi: 10.4103/0366-6999.233948.

本文引用的文献

1
Prognostic impact of blood pressure and heart rate at admission on in-hospital mortality after primary percutaneous intervention for acute myocardial infarction with ST-segment elevation in western Romania.罗马尼亚西部ST段抬高型急性心肌梗死患者直接经皮冠状动脉介入治疗后入院时血压和心率对院内死亡率的预后影响
Ther Clin Risk Manag. 2017 Aug 23;13:1061-1068. doi: 10.2147/TCRM.S141312. eCollection 2017.
2
Canada acute coronary syndrome score was a stronger baseline predictor than age ≥75 years of in-hospital mortality in acute coronary syndrome patients in western Romania.在罗马尼亚西部的急性冠状动脉综合征患者中,加拿大急性冠状动脉综合征评分比年龄≥75岁更能作为院内死亡率的基线预测指标。
Clin Interv Aging. 2016 Apr 26;11:481-8. doi: 10.2147/CIA.S104943. eCollection 2016.
3
Combined Usefulness of the Platelet-to-Lymphocyte Ratio and the Neutrophil-to-Lymphocyte Ratio in Predicting the Long-Term Adverse Events in Patients Who Have Undergone Percutaneous Coronary Intervention with a Drug-Eluting Stent.血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值联合应用对药物洗脱支架经皮冠状动脉介入治疗患者长期不良事件的预测价值
PLoS One. 2015 Jul 24;10(7):e0133934. doi: 10.1371/journal.pone.0133934. eCollection 2015.
4
Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention.休克指数作为直接经皮冠状动脉介入治疗后长期预后的一种新型预测指标。
Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):270-7. doi: 10.1177/2048872614561480. Epub 2014 Nov 25.
5
Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.10004 例接受监测血管造影的患者冠状动脉支架置入术后再狭窄的发生率和预测因素。
Heart. 2014 Jan;100(2):153-9. doi: 10.1136/heartjnl-2013-304933. Epub 2013 Nov 22.
6
Cardiovascular disease in Europe: epidemiological update.欧洲心血管疾病:流行病学最新进展。
Eur Heart J. 2013 Oct;34(39):3028-34. doi: 10.1093/eurheartj/eht356. Epub 2013 Sep 7.
7
Dietary strategies, policy and cardiovascular disease risk reduction in England.英格兰的饮食策略、政策与心血管疾病风险降低。
Proc Nutr Soc. 2013 Nov;72(4):386-9. doi: 10.1017/S0029665113001328. Epub 2013 Jul 10.
8
Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy.急性失代偿性心力衰竭时心率对预测非缺血性扩张型心肌病左心室逆向重构及治疗反应预后的临床意义。
Heart Vessels. 2014 Jan;29(1):88-96. doi: 10.1007/s00380-013-0335-0. Epub 2013 Mar 22.
9
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.2011年美国心脏病学会基金会/美国心脏协会/心血管造影和介入学会经皮冠状动脉介入治疗指南。美国心脏病学会基金会/美国心脏协会实践指南工作组及心血管造影和介入学会的报告。
J Am Coll Cardiol. 2011 Dec 6;58(24):e44-122. doi: 10.1016/j.jacc.2011.08.007. Epub 2011 Nov 7.
10
Systolic blood pressure at admission, clinical manifestations, and in-hospital outcomes in patients with acute myocardial infarction.急性心肌梗死患者入院时的收缩压、临床表现和住院结局。
J Cardiol. 2011 Jul;58(1):54-60. doi: 10.1016/j.jjcc.2011.04.003. Epub 2011 May 31.